Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Non-Current Assets (2019 - 2025)

Vivos Therapeutics has reported Non-Current Assets over the past 7 years, most recently at $20.8 million for Q4 2025.

  • Quarterly Non-Current Assets rose 165.88% to $20.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $67.6 million through Dec 2025, up 111.65% year-over-year, with the annual reading at $20.8 million for FY2025, 165.88% up from the prior year.
  • Non-Current Assets was $20.8 million for Q4 2025 at Vivos Therapeutics, up from $19.9 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $20.8 million in Q4 2025 and troughed at $5.2 million in Q1 2021.
  • The 5-year median for Non-Current Assets is $8.2 million (2023), against an average of $9.6 million.
  • The largest YoY upside for Non-Current Assets was 165.88% in 2025 against a maximum downside of 6.32% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $6.4 million in 2021, then surged by 30.34% to $8.3 million in 2022, then decreased by 0.33% to $8.3 million in 2023, then dropped by 5.54% to $7.8 million in 2024, then soared by 165.88% to $20.8 million in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Non-Current Assets are $20.8 million (Q4 2025), $19.9 million (Q3 2025), and $19.3 million (Q2 2025).